| Product Name | MF | CAS | Details |
|---|
| Isoetin | C15H10O7 | 1621-84-7 | Details |
| 4-(2-Methyl-1H-1,3-benzodiazol-1-yl)aniline | C14H13N3 | 869946-32-7 | Details |
| Titanium (IV) oxide - 99% | O2Ti | 13463-67-7 | Details |
| (2E)-2-(Pyridin-3-ylmethylidene)-2,3-dihydro-1H-indene-1,3-dione | C15H9NO2 | 31083-55-3 | Details |
| 1-(3-Bromo-5-fluorophenyl)-2-cyclopropylethan-1-amine | C11H13BrFN | 1270355-54-8 | Details |
| 2,4-Dinitrobenzaldehyde | C7H4N2O5 | 528-75-6 | Details |
| (N-Me-D-Phe7)-Bradykinin | C55H77N15O11 | 158873-14-4 | Details |
| Vanadium(IV) oxide | O2V | 12036-21-4 | Details |
| 3-Bromobutan-2-ol | C4H9BrO | 5798-80-1 | Details |
| 2,4-Dichloroquinoline-3-carbonitrile | C10H4Cl2N2 | 69875-54-3 | Details |
| V alpha 2 TCR antibody (PE) | Details |
| TMPRSS3 Blocking Peptide | Details |
| 4-[(3-Nitro-1H-pyrazol-1-yl)methoxy]benzaldehyde | C11H9N3O4 | 1006953-42-9 | Details |
| 4-oxo-2-spiro(N-Boc-piperidine-4-yl)-benzopyran | C18H23NO4 | 849928-22-9 | Details |
| 2-(4-(4-Fluorophenylamino)-3,5-thiazolyl)acetic acid | C11H9FN2O2S | 354124-90-6 | Details |
| 6'-N-Glycolylneuraminyl-D-lactose sodium salt | Details |
| (3S,4R)-Tofacitinib | C16H20N6O | 1092578-48-7 | Details |
| Methyl 1,2,3,4-tetrahydroisoquinoline-1-carboxylate hydrochloride | C11H14ClNO2 | 212958-77-5 | Details |
| Haegtftsdvs | C48H71N13O20 | 864915-61-7 | Details |
| Isoleucyl-Seryl-Bradykinin | Details |
| ZNF100 antibody | Details |
| 2-(4-Bromo-2-fluorophenyl)-5-methyl-1,3,4-oxadiazole | C9H6BrFN2O | 883230-92-0 | Details |
| 4-Propylpyrrolidin-2-one | C7H13NO | 89895-19-2 | Details |
| BLNK antibody (Tyr96) | Details |
| Matriptase antibody | Details |
| 5-(1,5-Dimethyl-1H-pyrazol-4-yl)-isoxazole-3-carboxylic acid | C9H9N3O3 | 957312-71-9 | Details |
| Ml 10302 hydrochloride | C15H22Cl2N2O3 | 186826-17-5 | Details |
| Activin A protein | Details |
| 1-Phenyl-3-(thiophen-2-yl)-1H-pyrazol-5-amine | C13H11N3S | 161952-26-7 | Details |
| ER-000444793 | C23H18N2O2 | 792957-74-5 | Details |
| 2-(2-Bromoethyl)-1,2-thiazolidine-1,1-dione | C5H10BrNO2S | 1157050-15-1 | Details |
| 3-Chloro-7-hydroxy-4-methylcoumarin | C10H7ClO3 | 6174-86-3 | Details |
| 6-Chloro-5-fluoropyridine-3-sulfonyl chloride | C5H2Cl2FNO2S | 1261737-06-7 | Details |
| 5-Fluoroquinoline-6-carbaldehyde | C10H6FNO | 1185768-17-5 | Details |
| D-(+)-Camphoric acid | C10H16O4 | 124-83-4 | Details |
| 2-[3-(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)-2-methoxypropyl]-2,3-dihydro-1H-isoindole-1,3-dione | C20H16N2O5 | 856832-79-6 | Details |
| 1-(3-Chloropropyl)-pyrrolidine hydrochloride | C7H15Cl2N | 57616-69-0 | Details |
| TRAIL Receptor 2 antibody | Details |
| 1,4,7-Oxadithionane | C6H12OS2 | 40474-73-5 | Details |
| Propane-2-sulfonyl fluoride | C3H7FO2S | 63805-73-2 | Details |
| MCP5 antibody | Details |
| Cyclopropylcarboxylic acid 1-piperazineamide hydrochloride | C8H15ClN2O | 1021298-67-8 | Details |
| 4-(Difluoromethoxy)-3-fluorobenzaldehyde | C8H5F3O2 | 1214379-56-2 | Details |
| 4-Chloro-2-methoxyaniline | C7H8ClNO | 93-50-5 | Details |
| 4-[(4-Aminonaphthalen-1-yl)oxy]butanenitrile | C14H14N2O | 1394042-68-2 | Details |
| (2R, 3R, 4R) -3, 4- Dihydroxy- 2- (hydroxymethyl) - 1- pyrrolidinepropanoic acid | C8H15NO5 | 1207674-35-8 | Details |
| 5-(Boc)-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid | C12H16N2O4S | 165948-21-0 | Details |
| KCTD17 antibody | Details |
| Ethyl 5-isopropyl-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylate | C16H20N2O3 | 338959-54-9 | Details |
| [1-(2,4-Dichlorophenyl)cyclohexyl]methanamine | C13H17Cl2N | 944348-13-4 | Details |
| Methyl 3-(pyridin-4-yl)propanoate | C9H11NO2 | 90610-07-4 | Details |
| 4-(Chloromethyl)-N,N-dimethylaniline hydrochloride | C9H13Cl2N | 1703-47-5 | Details |
| Cyclopentadienylmolybdenum(II) tricarbonyl, dimer | C16H10Mo2O610* | 12091-64-4 | Details |
| Barium selenite | BaO3Se | 13718-59-7 | Details |
| ATIC Blocking Peptide | Details |
| 1-(3-Bromopropyl)-3-nitro-1H-pyrazole | C6H8BrN3O2 | 1250489-44-1 | Details |
| 2-Carboxybenzoyl amlodipine | C28H29ClN2O8 | 318465-73-5 | Details |
| Fmoc-N-Lys-(dPEG?4-Biotin)-OH-(Acid) | C42H59N5O11S | 1334172-64-3 | Details |
| (3,3-difluorocyclopentyl)methanamine hcl | C6H12ClF2N | 1439900-13-6 | Details |
| 3,4-Dihydrospiro[1-benzopyran-2,3'-piperidine]-4-one hydrochloride | C13H16ClNO2 | 199105-26-5 | Details |
| 8-Oxo-5,6,7,8-tetrahydronaphthalene-2-sulfonyl chloride | C10H9ClO3S | 1152559-02-8 | Details |
| 5-(Chloromethyl)-5H,6H,7H,8H-imidazo[1,2-a]pyridine hydrochloride | 2219380-34-2 | Details |
| H-AGPHNDMEI-OH | Details |
| Methyl 3-[(2-methylpropyl)amino]propanoate | C8H17NO2 | 289656-94-6 | Details |
| 5H,6H,7H,8H-Imidazo[1,2-a]pyridin-7-amine | C7H11N3 | 1367938-31-5 | Details |
| N4-{7-Chloro-2-[2-(2-chloro-phenyl)-vinyl]-quinolin-4-yl}-N1,N1-diethyl-pentane-1,4-diamine | C26H31Cl2N3 | 10023-54-8 | Details |
| H-VAVVRTPPKSPSSAK-OH | Details |
| PALMD antibody | Details |
| 3-(4-Methoxy-2-methylphenyl)propan-1-ol | C11H16O2 | 568596-18-9 | Details |
| 3-[(Dimethylamino)sulfonyl]thiophene-2-carboxylic acid | C7H9NO4S2 | 944895-25-4 | Details |
| Warfarin alcohol | C19H18O4 | 28392-96-3 | Details |
| Methyl (3S)-3-amino-3-(2-methylphenyl)propanoate hydrochloride | C11H16ClNO2 | 1245606-66-9 | Details |
| 4-(bromomethyl)-3,5-dichloropyridine | C6H4BrCl2N | 159783-45-6 | Details |
| 1-(2-Chloroethoxy)-4-methanesulfonylbenzene | C9H11ClO3S | 34334-22-0 | Details |
| (2E)-3-[4-(Acetyloxy)-3-methoxyphenyl]-2-propenoyl chloride | C12H11ClO4 | 55882-65-0 | Details |
| EIF4E3 Blocking Peptide | Details |
| G6PD protein | Details |
| 4-(2-Phenylethyl)-1,3-oxazolidin-2-one | C11H13NO2 | 1276027-20-3 | Details |
| 7-Cinnamyl-8-(3,5-dimethyl-1H-pyrazol-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione | C20H20N6O2 | 1014072-96-8 | Details |
| 2-[(5-Methyl-1,3,4-thiadiazol-2-yl)methoxy]acetic acid | C6H8N2O3S | 1265895-84-8 | Details |
| Trans-cyclobutane-1,3-diol | C4H8O2 | 1332482-75-3 | Details |
| 4-Chloro-2-[(4-chlorophenyl)sulfanyl]benzoic acid | C13H8Cl2O2S | 20092-54-0 | Details |
| Valibose | C10H21NO6 | 83470-79-5 | Details |
| 3-(1H-Imidazol-1-yl)cyclohexan-1-one | C9H12N2O | 505062-29-3 | Details |
| 2-Bromoquinoline-8-carboxylic acid | C10H6BrNO2 | 1426144-88-8 | Details |
| 1-Cyclopropyl-2-(5,6-dimethyl-1H-1,3-benzodiazol-1-yl)ethan-1-amine dihydrochloride | C14H21Cl2N3 | 1376332-64-7 | Details |
| 5-[2-(2,3-Dihydro-1H-indol-1-yl)ethyl]-1,3,4-thiadiazol-2-amine | C12H14N4S | 1019111-89-7 | Details |
| 6-Azido-6-deoxy-2,3-O-isopropylidene-a-L-sorbofuranose | C9H15N3O5 | 126210-25-1 | Details |
| 1-(Difluoromethyl)-5-methyl-4-nitro-1H-pyrazole | C5H5F2N3O2 | 1245807-32-2 | Details |
| LAS-34823 | C16H24BrNO2 | 1708930-15-7 | Details |
| Galectin 3 antibody (HRP) | Details |
| [1-(2H-1,2,3-Triazol-2-yl)cyclopropyl]methanamine | C6H10N4 | 2287289-36-3 | Details |
| H-QTDAAVKNWMTQTLL-OH | Details |
| PRT 060318 | C18H24N6O | 1194961-19-7 | Details |
| N1-Cyclopropyl-N1-methylbenzene-1,4-diamine | C10H14N2 | 1095038-67-7 | Details |
| 5-Bromo-4-methyl-1,3-oxazole hydrochloride | C4H5BrClNO | 1955498-47-1 | Details |
| 1-o-Tolylbutane-1,3-dione | C11H12O2 | 56290-54-1 | Details |
| HT Cement | Details |
| 3,4,6-Tri-O-acetyl-2-azido-2-deoxy-a-D-galactopyranosyl fluoride | Details |
| Oxepane-4-sulfonyl chloride | C6H11ClO3S | 1465189-77-8 | Details |
| Product Total： Product Page： | ||||
| 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 | ||||